Home › Funds › Champlain Investment Partners, LLC › PEN

Champlain Investment Partners, LLC position in PEN

PENUMBRA INC · Health Care

Champlain Investment Partners, LLC reported holding 164,726 shares of PEN (PENUMBRA INC) in its Q3 2026 13F filing — a position valued at US$52.4M, representing 1.81% of its reported portfolio and ranking #4 among its reported holdings. Champlain Investment Partners, LLC has disclosed PEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)164.73K sh
Reported value held$52.44M
Portfolio Weight1.81%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Champlain Investment Partners, LLC's PEN position evolved

Champlain Investment Partners, LLC first disclosed a stake in PEN in Q3 2023 at 353,390 shares (US$85.5M). The position peaked in Q4 2024 at 1,495,957 shares, worth US$355.3M. Across 13 filings, Champlain Investment Partners, LLC increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 164,726 shares valued at US$52.4M — a reduction of -54,306 shares quarter over quarter.. Notable position changes include a 132% increase in Q1 2024 (shares fell 19% over the following quarter), a 42% trim in Q1 2025 (shares fell 4% over the following quarter), a 55% trim in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 353.39K $85.49M New
Q4 2023 467.89K $117.69M Add
Q1 2024 1.08M $242.06M Add
Q2 2024 1.28M $231.05M Add
Q3 2024 1.55M $300.79M Add
Q4 2024 1.50M $355.26M Reduce
Q1 2025 869.92K $232.63M Reduce
Q2 2025 743.71K $190.86M Reduce
Q3 2025 717.90K $181.86M Reduce
Q4 2025 601.80K $187.11M Reduce
Q1 2026 491.38K $161.36M Reduce
Q2 2026 219.03K $69.16M Reduce
Q3 2026 164.73K $52.44M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PEN and 13F data

PEN (PENUMBRA INC) is a Health Care company. 34 other funds we track also report a position in PEN — the largest reported positions include HBK INVESTMENTS L P (US$580.5M), ExodusPoint Capital Management, LP (US$344.3M), Balyasny Asset Management (US$344.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PEN

All PEN fund holders →

FAQ

How long has Champlain Investment Partners, LLC held PEN?

Champlain Investment Partners, LLC has disclosed PEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Champlain Investment Partners, LLC's current position in PEN?

As of Q3 2026, Champlain Investment Partners, LLC holds 164.73K shares of PEN (PENUMBRA INC), valued at $52.44M, representing 1.81% of its reported portfolio and ranking #4.

Has Champlain Investment Partners, LLC been buying or selling PEN?

In the latest 13F filing (Q3 2026), Champlain Investment Partners, LLC reduced its position in PEN. The position peaked in Q4 2024 at 1.50M shares.

Which other funds hold PEN?

Other major institutional holders of PEN include HBK INVESTMENTS L P, ExodusPoint Capital Management, LP, Balyasny Asset Management, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.